XML 92 R71.htm IDEA: XBRL DOCUMENT v3.26.1
EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Net Income for Earnings Per Share Calculations:            
Income from continuing operations, net of tax $ 241.4   $ 335.9   $ 622.1 $ 699.5
Loss from discontinued operations, net of tax 0.0   (4.4)   0.0 (11.6)
Net income 241.4 $ 380.7 331.5 $ 356.4 622.1 687.9
Less: Net loss attributable to noncontrolling interests (0.5)   (1.7)   (0.5) (3.3)
Net income attributable to Edwards Lifesciences Corporation $ 241.9   $ 333.2   $ 622.6 $ 691.2
Weighted Average Shares:            
Basic weighted-average shares outstanding (in shares) 576.4   587.0   577.8 586.9
Dilutive effect of stock plans (in shares) 1.2   0.9   1.4 1.0
Dilutive weighted-average shares outstanding (in shares) 577.6   587.9   579.2 587.9
Basic:            
Continuing operations (in dollars per share) $ 0.42   $ 0.58   $ 1.08 $ 1.20
Discontinued operations (in dollars per share) 0   (0.01)   0 (0.02)
Basic earnings per share (in dollars per share) 0.42   0.57   1.08 1.18
Diluted:            
Continuing operations (in dollars per share) 0.42   0.57   1.07 1.20
Discontinued operations (in dollars per share) 0   (0.01)   0 (0.02)
Diluted earnings per share (in dollars per share) $ 0.42   $ 0.56   $ 1.07 $ 1.18